Toronto: Imagine a fighter jet that can fly to its target undetected, attack 
with two different kinds of weapons and then disappear without a trace. 
Now imagine that the target is a cancer cell, and that the fighter jet 
is a particle so small that 60 billion of them could fit on the head of a
 pin. This is the principle behind a new type of nanomedicine developed by Professor Warren Chan (IBBME) and Vahid Raeesi (MSE
 PhD 1T6) at U of T Engineering. Their cancer-fighting nanoparticles are
 modular, meaning they are put together from even smaller pieces, in 
this case, tiny bits of gold and DNA. Each component plays a role in the
 multi-part mission to treat cancer more effectively while reducing the 
side effects relative to current options.
“Tumours within the body are complex systems,” says Raeesi. “To 
interact with them, you need particles that are equally complex, 
adaptable and interactive. They need to change their properties and 
behaviour in order to complete different tasks at different times.”
The
 first task is to reach the cancer cells, which involves running a 
gauntlet past the body’s immune system, whose white blood cells are 
designed to capture and eject anything they identify as foreign. Once 
the particles reach the tumour, the next step is to deliver the payload,
 such as an anti-cancer drug, in a controlled, effective manner. 
Finally, the particles need to degrade so that they don’t damage 
non-cancerous cells once their mission is through.
To complete all
 these tasks, Raeesi and Chan built their new nanoparticles out of 
several parts, each of which completes a different task. At their core 
are gold nanorods about 7 nanometres wide and 28 nanometres long. These 
rods heat up when exposed to infrared light, which can be delivered by 
shining a laser through the skin. The heat destroys nearby cancer cells.
Gold
 nanorods have been used by other groups in the past, but their size and
 surface chemistry make them prone to being caught by the immune system.
 To deal with this problem, the team added 20 to 30 “satellites” made of
 tiny gold spheres that are coated with polyethylene glycol, a polymer. 
The satellites are linked to the central core with strands of DNA. By 
changing the size and surface chemistry of the particles, the outer 
spheres allow them to travel in stealth mode past the immune system 
until they reach the tumour.
In addition to linking the satellites
 to the core, the strands of DNA have a second function; incorporated 
into their structure are molecules of doxorubicin, an anti-cancer drug. 
Once they reach the tumour, Raeesi can use the laser to heat up the 
nanorods at the core. The heat kills cancer cells, but it also breaks 
the DNA strands, which releases the doxorubicin at precisely the right 
moment and location. The combination of heat and drugs can kill more 
cells than either method alone
The final task is to disappear. 
After the modular nanoparticles break apart, the leftover pieces are 
small enough that they would disperse into the bloodstream and be 
filtered out by the kidneys. This ensures that they don’t continue to 
cause damage after the treatment is complete.
Raeesi’s work, recently published in the journal Advanced Materials,
 showed that drug storage and release rate can be increased by 
controlling the DNA sequence chemistry and laser intensity. In the 
future, he envisions incorporating even more functions, such as contrast
 agents that could help tumours become more visible in MRI scans or 
co-delivery of multiple drugs in the case of drug-resistant cancers.
“Each
 component, each building block can do something for you,” says Raeesi. 
“Until now, we didn’t have a modular system like this to controllably 
deliver multiple therapeutics.”
